XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
3.825
+0.025 (0.66%)
At close: Mar 25, 2024, 4:00 PM
3.540
-0.285 (-7.45%)
After-hours: Mar 27, 2024, 7:58 PM EDT

XORTX Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Selling, General & Admin
2.941.280.530.29
Research & Development
8.810.850.280.04
Other Operating Expenses
1.631.520.560.24
Operating Expenses
13.393.651.370.57
Operating Income
-13.39-3.65-1.37-0.57
Interest Expense / Income
-0.140.010.010.04
Other Expense / Income
-3.76-2-0.090.03
Pretax Income
-9.49-1.65-1.28-0.63
Net Income
-9.49-1.65-1.28-0.63
Shares Outstanding (Basic)
1111
Shares Outstanding (Diluted)
1111
Shares Change
35.25%47.77%24.34%-
EPS (Basic)
-6.39-1.53-1.71-1.08
EPS (Diluted)
-6.39-1.53-1.71-1.08
Free Cash Flow
-11.99-6.06-0.73-0.25
Free Cash Flow Per Share
-8.11-5.54-0.98-0.42
EBITDA
-9.55-1.63-1.25-0.57
Depreciation & Amortization
0.080.020.020.02
EBIT
-9.62-1.65-1.27-0.59
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).